Rapporten
Verificerede nyheder om finansiering, hovedkvarterer og ledelse fra verdens mest innovative virksomheder
8 rapporter og tæller
Abcuro Raises $66M Series D for Inclusion Body Myositis Trial
Abcuro raised a $66 million Series D led by New Leaf Venture Partners to fund a new potentially registrational study of ulviprubart in inclusion body myositis.
Claris Bio Raises $118M Series B for Limbal Stem Cell Deficiency Therapy
Claris Bio closed a $118 million Series B co-led by Samsara Biocapital and Catalio Capital Management to fund trials and a planned pivotal program in limbal stem cell deficiency.
Samsara Raises $300M in Series G
Samsara, a Logistics company based in San Francisco, CA, has raised $300M in Series G at a $10.8B valuation led by Tiger Global, Andreessen Horowitz, General Catalyst.
Samsara raises $300M Series F at $5.4B valuation
Samsara raises $300M in Series F at $5.4B valuation. Connected operations cloud platform...
Samsara Headquarters - Office Location & Address
Discover Samsara's headquarters at 1 De Haro St, San Francisco, CA 94107. IoT platform for operations. Learn about the office facilities and work environment.
Graphite Bio Raises $238M in Series B
Graphite Bio, a Biotech company based in 279 East Grand Avenue, South San Francisco, CA 94080, has raised $238M in Series B at a $1B valuation led by ARCH Venture Partners, Vida Ventures, Norwest Venture Partners, Samsara BioCapital.
Normunity raises $75M Series B at $500M valuation
Normunity raises $75M in Series B at $500M valuation. T cell engager therapies...
Graphite Bio raises $238M Series B at $1B valuation
Graphite Bio raises $238M in Series B at $1B valuation. Precision genetic medicines...
Viser 8 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.